MKRN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.55069999999902E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.25859999999356E-05 |
Normal-vs-Stage2 |
1.656050E-03 |
Normal-vs-Stage3 |
5.099700E-03 |
Normal-vs-Stage4 |
3.38950000000615E-06 |
Stage1-vs-Stage2 |
8.368600E-01 |
Stage1-vs-Stage3 |
6.429200E-01 |
Stage1-vs-Stage4 |
3.200100E-02 |
Stage2-vs-Stage3 |
8.662800E-01 |
Stage2-vs-Stage4 |
1.664950E-01 |
Stage3-vs-Stage4 |
2.092600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.00790000000062E-05 |
Normal-vs-AfricanAmerican |
1.917450E-03 |
Normal-vs-Asian |
2.028400E-01 |
Caucasian-vs-AfricanAmerican |
7.849000E-01 |
Caucasian-vs-Asian |
8.124600E-01 |
AfricanAmerican-vs-Asian |
7.507400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.23890000003346E-06 |
Normal-vs-Female |
1.061200E-01 |
Male-vs-Female |
2.469500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.97710000000063E-05 |
Normal-vs-Extreme_Weight |
2.27809999997497E-06 |
Normal-vs-Obese |
1.141210E-03 |
Normal-vs-Extreme_Obese |
7.572000E-02 |
Normal_Weight-vs-Extreme_Weight |
9.720600E-01 |
Normal_Weight-vs-Obese |
3.864600E-01 |
Normal_Weight-vs-Extreme_Obese |
7.124400E-01 |
Extreme_Weight-vs-Obese |
2.990600E-01 |
Extreme_Weight-vs-Extreme_Obese |
6.975200E-01 |
Obese-vs-Extreme_Obese |
8.827600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.703600E-02 |
Normal-vs-Age(41-60Yrs) |
1.677770E-03 |
Normal-vs-Age(61-80Yrs) |
1.62800000003127E-06 |
Normal-vs-Age(81-100Yrs) |
1.643040E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.997600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.239600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.433200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.213960E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.857200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.532400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
6.397400E-04 |
Normal-VS-Type2 PRCC |
8.0098000010409E-08 |
Normal-VS-KIRP CIMP |
2.920100E-02 |
Normal-VS-Unclassified PRCC |
2.571800E-01 |
Type1 PRCC-VS-Type2 PRCC |
2.196700E-03 |
Type1 PRCC-VS-KIRP CIMP |
9.407200E-01 |
Type1 PRCC-VS-Unclassified PRCC |
4.972600E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.059800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.550500E-02 |
KIRP CIMP-VS-Unclassified PRCC |
5.361800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.29110000024468E-07 |
Normal-vs-N1 |
3.50129999999726E-05 |
Normal-vs-N2 |
4.649500E-04 |
N0-vs-N1 |
4.207400E-01 |
N0-vs-N2 |
4.785200E-01 |
N1-vs-N2 |
1.881800E-01 |
|
|